

Publisher: Informa Healthcare
ISSN: 1354-3776
Source: Expert Opinion on Therapeutic Patents, Vol.8, Iss.8, 1998-08, pp. : 1049-1051
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Partial Agonists for A3 Adenosine Receptors
Current Topics in Medicinal Chemistry, Vol. 4, Iss. 8, 2004-04 ,pp. :


By Hasko G. Nemeth Z.H. Vizi E.S. Salzman A.L. Szabo C.
European Journal of Pharmacology, Vol. 358, Iss. 3, 1998-10 ,pp. :


Adenosine A 3 receptors: novel ligands and paradoxical effects
Trends in Pharmacological Sciences, Vol. 19, Iss. 5, 1998-05 ,pp. :


Purine Derivatives as Ligands for A3 Adenosine Receptors
Current Topics in Medicinal Chemistry, Vol. 5, Iss. 13, 2005-10 ,pp. :